4.2 Dilated, Non-Compaction & Arrhythmogenic Ventricular Cardiomyopathies

4.2 Dilated, Non-Compaction & Arrhythmogenic Ventricular Cardiomyopathies

Clinical Core: Myocardial disorders characterized by ventricular dilation, abnormal compaction architecture, or fibrofatty replacement represent significant clinical challenges in pediatric cardiology. Dilated cardiomyopathy (DCM) is the primary cause of childhood congestive heart failure and pediatric heart transplantation. Left ventricular non-compaction (LVNC) and arrhythmogenic right ventricular cardiomyopathy (ARVC) present unique diagnostic dilemmas where distinguishing developmental non-compaction from normal apical trabeculations, or fibrofatty dysplasia from normal right ventricular variants, is vital to prevent both under-diagnosis of lethal arrhythmogenic disease and unwarranted restriction of healthy young individuals.

---

Pediatric Dilated Cardiomyopathy (DCM): Etiologies & Pathophysiology

Dilated cardiomyopathy is the most frequent cardiomyopathy in children, accounting for 50% to 60% of all pediatric cardiomyopathy diagnoses. It displays a distinct bimodal age distribution, peaking prominently during the first year of life (infantile presentation) and experiencing a secondary peak in mid-to-late adolescence. Pathophysiologically, DCM is characterized by progressive ventricular dilation and impaired global systolic contractility in the absence of abnormal hemodynamic loading conditions (such as severe aortic valve stenosis, aortic coarctation, or systemic hypertension).

Primary Etiological Categories

1. Viral Myocarditis & Post-Viral Autoimmunity (~40%):
   • The leading identifiable cause of acute-onset DCM in previously healthy infants and children.
   • Primary viral agents include Enteroviruses (Coxsackievirus B), Parvovirus B19, Adenovirus, Human Herpesvirus 6 (HHV-6), and SARS-CoV-2 (including post-infectious Multisystem Inflammatory Syndrome in Children [MIS-C]).
   • Pathogenesis proceeds through two phases: initial direct viral-mediated cardiomyocyte entry and lysis, followed by secondary auto-reactive T-cell and antibody-mediated immune infiltration, microvascular ischemia, and progressive myocyte replacement fibrosis.
2. Familial & Genetic Mutations (30%–40%):
   • Inherited primarily as an autosomal dominant trait, although X-linked, autosomal recessive, and mitochondrial patterns occur.
   • TTN (Titin): Truncating variants in TTN represent the most prevalent genetic etiology of familial DCM.
   • LMNA (Lamin A/C): Nuclear envelope gene mutations associated with a notoriously aggressive phenotype characterized by progressive atrioventricular conduction block, malignant ventricular tachyarrhythmias, and high rates of sudden cardiac death, often preceding overt chamber dilation.
   • Sarcomeric & Cytoskeletal Genes: MYH7, TNNT2, ACTC1, DES (desmin), and DMD (dystrophin).
3. Metabolic, Neuromuscular & Mitochondrial Disorders:
   • Primary Carnitine Deficiency (SLC22A5 / OCTN2 defect): Defective carnitine transport causing urinary carnitine wasting, impaired mitochondrial fatty acid beta-oxidation, lipid accumulation in myocytes, and severe infantile DCM dramatically responsive to oral L-carnitine supplementation.
   • Barth Syndrome (TAZ gene): X-linked recessive disorder causing defective tafazzin-mediated cardiolipin remodeling in the inner mitochondrial membrane, presenting with infantile DCM or LVNC, cyclic neutropenia, skeletal myopathy, and 3-methylglutaconic aciduria.
   • Duchenne & Becker Muscular Dystrophies: X-linked dystrophin mutations causing progressive posterolateral LV fibrosis transitioning into overt DCM during the second decade.

---

Quantitative Echocardiographic Evaluation of DCM

Pediatric echocardiographic assessment of DCM demands rigorous quantitative indexing to body surface area (BSA) using validated pediatric Z-scores:

1. Chamber Sizing & Geometric Remodeling

• Left Ventricular Cavity Dimensions: Left ventricular end-diastolic dimension (LVEDD) and end-systolic dimension (LVESD) measured in the parasternal short-axis or long-axis view at the mitral chordal level. An LVEDD Z-score > +2.0 establishes abnormal dilation; decompensated pediatric DCM frequently presents with Z-scores between +4.0 and +8.0.
• Sphericity Index: The healthy left ventricle exhibits an elongated, prolate ellipsoid geometry. In DCM, progressive volume overload and elevated wall stress induce spherical remodeling. The sphericity index is calculated in the apical four-chamber view at end-diastole: $\text{Sphericity Index} = \frac{\text{LV Major-Axis Length}}{\text{LV Minor-Axis Width}}$ Normal pediatric values are > 1.5 to 2.0. In severe DCM, spherical remodeling causes the sphericity index to drop toward 1.0 (a globular, spherical chamber).
• Relative Wall Thickness (RWT): Calculated as $2 \times \text{LVPWd} / \text{LVEDD}$. In DCM, despite increased total LV myocardial mass, RWT is markedly reduced (RWT < 0.30), reflecting disproportionate chamber dilation relative to wall thickness (eccentric hypertrophy).

2. Systolic Performance Quantification

• Fractional Shortening (FS): Measured via 2D-directed M-mode: $\text{FS (\%)} = \frac{\text{LVEDD} - \text{LVESD}}{\text{LVEDD}} \times 100$ Normal pediatric FS is 28% to 44%. An FS < 25% denotes systolic depression; severe DCM exhibits FS values below 15%.
• Biplane Simpson's Ejection Fraction (LVEF): Method of disks in apical 4- and 2-chamber views. Normal LVEF is 55% to 70%. In DCM, LVEF drops to < 45%, and frequently < 25% in acute decompensation.
• E-Point Septal Separation (EPSS): Measured on M-mode across the mitral valve leaflets in the parasternal long-axis view. Normal pediatric EPSS is < 5 to 6 mm. In DCM, EPSS increases to > 7 to 15 mm. This separation results from two synergistic factors:
  1. Reduced Forward Stroke Volume: Low transvalvular inflow volume fails to physically swing the anterior leaflet fully open toward the septum.
  2. Anatomical Chamber Dilation: Physical enlargement of the left ventricular cavity displaces the interventricular septum anteriorly away from the mitral apparatus.
• Tissue Doppler Imaging (TDI) s' Velocity: Peak systolic myocardial annular velocity at the septal and lateral mitral annulus drops significantly (s' < 5–6 cm/s; normal pediatric s' is 8–12 cm/s).

3. Functional Mitral Regurgitation & Thrombus Surveillance

• Secondary (Functional) Mitral Regurgitation: Left ventricular cavity enlargement and spherical remodeling displace the papillary muscles laterally and apically. This induces systolic tethering (tenting) of the mitral leaflets, preventing complete coaptation and producing a centrally directed regurgitant jet.
• Spontaneous Echo Contrast & Apical Mural Thrombi: Low-velocity blood flow and cavity stasis generate spontaneous echo contrast ('smoke'). High-frequency imaging focused directly on the apex is mandatory to detect apical mural thrombi, which carry severe risks of systemic thromboembolism and stroke.

---

Left Ventricular Non-Compaction (LVNC): Embryology & Criteria

Left ventricular non-compaction is a distinct primary cardiomyopathy characterized by prominent, excessive ventricular trabeculations and deep intertrabecular recesses that penetrate deep into the myocardial wall.

Normal Myocardial Compaction (Weeks 5-8):       Arrested Compaction (LVNC):

 Epicardium ───────────────                    Epicardium ───────────────
            │ Solid, Dense                                │ Thin Compacted Layer (C)
            │ Compacted                                   ├───────────────
            │ Myocardium                                  │ Deep Recesses
            │                                             │ & Heavy Trabeculations
 Endocardium ───────────────                    Endocardium ──┴───┴───┴─── (NC Layer)
  (Smooth endocardial border)                      (Jenni Ratio: NC / C > 2.0 at End-Systole)

Embryological Mechanism

During embryonic weeks 5 through 8, the embryonic myocardium undergoes a process of compaction, transforming from a loose, sponge-like meshwork of interwoven myocardial fibers into solid, compacted tissue. Compaction proceeds sequentially from the epicardium to the endocardium and from the cardiac base to the apex. Premature arrest of this normal developmental process leaves the inner endocardial layer persistently non-compacted.

Anatomical Distribution

Non-compaction predominantly affects the cardiac apex, mid-lateral wall, and mid-inferior wall. Importantly, the basal interventricular septum is almost universally spared and exhibits normal compaction. Non-compaction involving the basal septum should raise suspicion for an alternative diagnosis or prominent false tendons.

Echocardiographic Diagnostic Criteria

• Jenni Criteria (End-Systolic Short-Axis - Gold Standard): $\frac{\text{Non-Compacted Endocardial Layer (NC)}}{\text{Compacted Epicardial Layer (C)}} > 2.0$ Measured at the site of maximal thickness in the parasternal short-axis view at end-systole in a two-layered myocardial architecture.
• Chin Criteria (End-Diastolic Apical): Evaluated at end-diastole on apical views as the ratio $X/Y \le 0.5$, where $X$ is the distance from epicardium to the trough of the trabeculation, and $Y$ is the distance from epicardium to the peak of the trabeculation.
• Color Doppler Interrogation: Essential to confirm the diagnosis. Low-velocity scale color Doppler demonstrates intracavitary blood flowing freely into and filling the deep intertrabecular recesses directly from the LV cavity, with no communication with the epicardial coronary circulation (differentiating LVNC from coronary cameral fistulae).

The Clinical Complication Triad of LVNC

1. Progressive Heart Failure: Systolic pump failure and severe diastolic dysfunction resulting from abnormal subendocardial microvascular perfusion and dyssynchronous compaction mechanics.
2. Ventricular Arrhythmias & Conduction Defects: Monomorphic and polymorphic ventricular tachycardia, bundle branch blocks, and ventricular pre-excitation (Wolff-Parkinson-White [WPW] syndrome, present in up to 15% of pediatric cases).
3. Systemic Thromboembolism: Sluggish blood flow and stasis within deep intertrabecular recesses promote micro-thrombus formation, predisposing to strokes, transient ischemic attacks, and peripheral embolization.

---

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC / ACM)

Arrhythmogenic right ventricular cardiomyopathy (ARVC)—now frequently termed arrhythmogenic cardiomyopathy (ACM) to reflect frequent biventricular or left-dominant involvement—is a genetically determined heart muscle disorder characterized by progressive fibrofatty replacement of ventricular myocardium.

Molecular Genetics & Pathogenesis

ARVC is predominantly a disease of the cardiac desmosome, inherited in an autosomal dominant manner with variable penetrance:

• Desmosomal gene mutations disrupt cell-cell mechanical junctions (intercalated discs). Under mechanical stretch and physical exercise, desmosomes detach, triggering cardiomyocyte death, reactive fibrofatty repair, and severe electrical instability.
• Key Desmosomal Genes: PKP2 (Plakophilin-2) (most common, ~40–50%), DSP (Desmoplakin) (associated with left-dominant forms), DSG2 (Desmoglein-2), and DSC2 (Desmocollin-2).
• Cardiocutaneous Syndromes (Autosomal Recessive):
  • Naxos Disease: Mutation in JUP (plakoglobin); ARVC combined with woolly hair and diffuse palmoplantar keratoderma.
  • Carvajal Syndrome: Mutation in DSP (desmoplakin); left-dominant dilated cardiomyopathy with woolly hair and keratoderma.

The 'Triangle of Dysplasia'

Fibrofatty replacement in ARVC typically initiates in three anatomically vulnerable right ventricular regions:

1. Right Ventricular Outflow Tract (RVOT) / Infundibulum
2. Right Ventricular Apex
3. Inflow Tract (Subtricuspid Region)

                      [RVOT / Infundibulum]
                               ▲
                              / \
                             /   \
                            /     \
                           /       \
                          /  ARVC   \
                         / Triangle  \
                        /      of     \
                       /   Dysplasia   \
                      /                 \
                     ▼                   ▼
           [Subtricuspid Inflow] ───────► [RV Apex]

---

Echocardiographic Diagnosis: 2010 Revised Task Force Criteria

Diagnosis of ARVC requires fulfillment of standardized multimodality criteria (incorporating imaging, histology, ECG, arrhythmias, and family history). Echocardiographic criteria require the presence of regional RV wall motion abnormalities (akinesis, dyskinesis, or aneurysm) plus quantitative RV chamber enlargement or functional impairment:

2010 Task Force Echocardiographic Criteria for ARVC

Additional Diagnostic Features in ARVC

• RV Fractional Area Change (FAC): Calculated in the apical 4-chamber view: $\text{FAC (\%)} = \frac{\text{End-Diastolic Area} - \text{End-Systolic Area}}{\text{End-Diastolic Area}} \times 100$
• Tricuspid Annular Plane Systolic Excursion (TAPSE): Typically depressed (< 16–17 mm or age-adjusted Z-score < -2.0).
• Tissue Doppler s' Velocity: RV free wall tricuspid annular $s'$ velocity is reduced (< 9.5 cm/s).
• Structural Morphological Anomalies: Localized sacculations, diastolic bulging, end-systolic sacculations, hyper-reflective moderator bands, and regional microaneurysms within the triangle of dysplasia.

---

Pediatric Diagnostic Comparison: DCM vs. LVNC vs. ARVC

---

Clinical Pearls & Sonographic Traps

[!WARNING] The Apical Trabeculation Overdiagnosis Trap: Overdiagnosis of LVNC is an exceedingly common clinical pitfall. Normal children, highly trained adolescent endurance athletes, and individuals with chronic volume loading (such as sickle cell anemia or large left-to-right shunts) frequently exhibit prominent apical trabeculations and aberrant bands. Never diagnose LVNC based solely on apical 4-chamber inspection. The Jenni criterion (NC/C > 2.0 at end-systole in parasternal short-axis) must be strictly fulfilled, accompanied by demonstration of cavity blood washing into deep recesses on color Doppler.

[!NOTE] The Dilated Left Ventricle Axiom (Rule Out ALCAPA): Any infant or young child presenting with unexplained left ventricular dilation, depressed systolic function, or moderate-to-severe mitral regurgitation must be presumed to have Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery (ALCAPA) until both coronary artery ostia are unambiguously proven to arise from the aorta. Overlooking ALCAPA in an infant labeled as 'idiopathic dilated cardiomyopathy' is a fatal diagnostic error.

[!TIP] Accurate RVOT Dimensioning for ARVC: To avoid false-positive ARVC diagnoses in athletic adolescents, ensure RVOT dimensions in the parasternal long-axis view are measured strictly perpendicular to the aortic root at end-diastole. Do not measure obliquely across the infundibulum.